Role of Enhanced Recovery after Surgery (ERAS) Protocol in the Management of Elderly Patients with Glioblastoma.

ERAS elderly enhanced recovery after surgery glioblastoma neurosurgery

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
18 Sep 2023
Historique:
received: 07 07 2023
revised: 17 08 2023
accepted: 14 09 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Among the already difficult management of neuro-oncological patients, the elderly population remains vulnerable. Because of the pathology and the comorbidities, they present a significantly higher rate of medical issues related to surgical management. Despite this, the surgical option, if feasible, remains the gold standard in these patients, and an Enhanced Recovery After Surgery (ERAS) protocol could improve the postoperative safety of the patients. With this purpose, we prepared this study with the aim of defining the postoperative hospital length of stay (LOS), but also of evaluating the postoperative morbidity, perioperative complications, and postoperative pain scores. This was a retrospective, single-cohort study performed at an academic hospital (Department of Neurosurgery, Neurocenter of South Switzerland, Switzerland) on elderly patients who underwent craniotomy for glioblastoma. Patients were enrolled in a novel ERAS protocol from January 2022 to December 2022. Since this is a feasibility study and a direct comparison was not possible, we used a historical cohort of elderly patients who had undergone elective craniotomy surgery for glioblastoma as a control group. A total of 19 patients treated in our center for glioblastoma multiforme (GBM) who were aged over 75 years were included in this study. Among those, seven were newly recruited patients included in the ERAS protocol, while the remaining twelve were part of a historical cohort of previously treated patients. From a statistical point of view, the two cohorts were comparable in terms of baseline demographics. In the follow-up, it was shown that in the ERAS group, there was a reduction in the use of opioids after the surgical procedures that could be seen at 30 days (36.2% vs. 71.7%, The ERAS protocol for the management of glioblastoma in elderly patients seems to be an effective option for reducing LOS in the hospital, as well as for reducing the number of days spent in the ICU, improving the general recovery of the patient, and reducing the costs associated with hospitalization.

Identifiants

pubmed: 37762972
pii: jcm12186032
doi: 10.3390/jcm12186032
pmc: PMC10531564
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Neurosurg Anesthesiol. 2014 Jan;26(1):32-6
pubmed: 23764718
Br J Anaesth. 1997 May;78(5):606-17
pubmed: 9175983
Clin Neurol Neurosurg. 2018 Jan;164:142-153
pubmed: 29232645
JAMA Surg. 2017 Mar 1;152(3):292-298
pubmed: 28097305
BMC Neurol. 2021 Mar 19;21(1):127
pubmed: 33740911
Br J Surg. 2008 Nov;95(11):1331-8
pubmed: 18844267
J Neurosurg Spine. 2017 Apr;26(4):411-418
pubmed: 28009223
World Neurosurg. 2017 Aug;104:24-38
pubmed: 28478245
BMJ Open. 2019 Nov 10;9(11):e028706
pubmed: 31712331
Neurosurg Focus. 2019 Apr 1;46(4):E3
pubmed: 30933920
Neurosurgery. 2018 Oct 1;83(4):827-834
pubmed: 28945854
J Neurosurg. 2018 Jun 1;:1-12
pubmed: 29932379
BMC Anesthesiol. 2019 Jun 1;19(1):91
pubmed: 31153358
Neurochirurgie. 2022 Jan;68(1):61-68
pubmed: 33901525
Obes Surg. 2019 Jul;29(7):2100-2109
pubmed: 30937877
J Clin Neurosci. 2016 Feb;24:10-6
pubmed: 26474504
World J Surg. 2013 Aug;37(8):1909-18
pubmed: 23568250
Clin Nutr. 2005 Jun;24(3):466-77
pubmed: 15896435
Arch Surg. 2009 Oct;144(10):961-9
pubmed: 19841366
Int J Gynecol Cancer. 2023 Aug 7;33(8):1279-1286
pubmed: 37451690
J Vasc Surg. 2019 Aug;70(2):629-640.e1
pubmed: 30922754
Neurosurg Focus. 2019 Apr 01;46(4):E2
pubmed: 31018257

Auteurs

Ismail Zaed (I)

Department of Neurosurgery, Neurocenter of South Switzerland, EOC, via Tesserete 44, 6900 Lugano, Switzerland.

Francesco Marchi (F)

Department of Neurosurgery, Neurocenter of South Switzerland, EOC, via Tesserete 44, 6900 Lugano, Switzerland.

Davide Milani (D)

Department of Neurosurgery, Neurocenter of South Switzerland, EOC, via Tesserete 44, 6900 Lugano, Switzerland.

Ivan Cabrilo (I)

Department of Neurosurgery, Neurocenter of South Switzerland, EOC, via Tesserete 44, 6900 Lugano, Switzerland.

Andrea Cardia (A)

Department of Neurosurgery, Neurocenter of South Switzerland, EOC, via Tesserete 44, 6900 Lugano, Switzerland.

Classifications MeSH